ScreenerHero

NUTEX NUTEX Investments Public Limited Company

BUD · HU · Healthcare · Drug Manufacturers - Specialty & Generic · nutex.hu
12.35HUF+3.78%Mkt Cap: 5.98M $P/E: 2.03

NUTEX Investments Public Limited Company provides health preserving, health promotion, nutritional supplement, and cosmetic products in Hungary and internationally. It also engages in asset management. The company was fo…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap5.98M USD
Enterprise Value-12.19M USD
Revenue (TTM)1.27K USD
Gross Profit1.27K USD
Net Income (TTM)1.40M USD
Revenue/Share0.0030 HUF
Last Price12.35 HUF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryHU
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)2.03
P/E (Forward)—
PEG—
EV/EBITDA67.63
EV/Revenue-9581.82
P/S4527.57
P/B0.25
EPS (TTM)3.40
EPS (Forward)—
52W Range
11.0021% of range17.35
52W High17.35 HUF
52W Low11.00 HUF
Profitability
Gross Margin100.00%
Oper. Margin-35840.44%
EBITDA Margin0.00%
Profit Margin109815.78%
ROE8.96%
ROA8.90%
Growth
Revenue Growth0.00%
Earnings Growth301.10%
Cash Flow & Leverage
Operating CF724.41K USD
CapEx (TTM)1.15K USD
FCF Margin-46234.28%
FCF Yield-9.84%
Net Debt-16.57M USD
Net Debt/EBITDA91.96
Balance Sheet
Debt/Equity—
Current Ratio645.10
Quick Ratio645.07
Book Value/Sh46.83 HUF
Cash/Share45.08 HUF
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 HUF
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 6, 2011
Pay Date—
Splits
Last Split1:100
Split DateMar 7, 2011
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.171.21M
Float88.75M
Insiders29.40%
Institutions0.00%
Technical
SMA 5012.76 (-3.2%)
SMA 20013.88 (-11.0%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)104.96K
Avg Vol (10d)35.52K
Technical Indicators
RSI (14)48.2
MACD-0.1692
MACD Signal-0.1623
MACD Hist.-0.0070
BB Upper13.09 HUF
BB Middle12.42 HUF
BB Lower11.74 HUF
BB Width10.88%
ATR (14)0.5889 HUF
Vol Ratio (20d)0.42x